← Back to Search

Active tDCS for Psychosis

N/A
Waitlist Available
Led By Ian S Ramsay, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3-5 weeks
Awards & highlights

Study Summary

This trial will study whether a noninvasive brain stimulation technique can improve cognitive remediation therapy for people with psychotic disorders.

Eligible Conditions
  • Psychosis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3-5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Brief Assessment of Cognition in Schizophrenia (BACS) from Baseline to Post-Training
Change in N-Back from Baseline to Post-Training
Change in VRFCAT from Baseline to Post-Training

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active tDCSActive Control1 Intervention
The active tDCS will be applied at a current of 1-2mA via two saline soaked electrode sponges (3 cm x 4.5 cm) for the first 20 minutes of each CRT session in the active condition.
Group II: Sham tDCSPlacebo Group1 Intervention
In the sham condition, tDCS will be ramped up to 1-2 mA via two saline soaked electrode sponges (3 cm x 4.5 cm) over the first 30 seconds of each CRT session and then turned off.

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,386 Previous Clinical Trials
1,552,336 Total Patients Enrolled
11 Trials studying Psychosis
1,581 Patients Enrolled for Psychosis
Ian S Ramsay, PhDPrincipal InvestigatorUniversity of Minnesota

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new participants still being accepted for this clinical experiment?

"Affirmative, the records on clinicaltrials.gov demonstrate that this research is searching for individuals to participate in their study. It was initially posted on March 14th 2019 and modified most recently November 14th 2022. This investigation requires 85 participants from a single medical facility."

Answered by AI

Are individuals aged 50+ being accepted into the clinical trial?

"As outlined by the eligibility criteria, only patients between 18 and 64 years of age can enroll in this study. In contrast, 116 studies are available to those under eighteen while 262 are suitable for individuals over 65."

Answered by AI

Would I be eligible to join this medical experiment?

"This experimental research necessitates 85 participants to be suffering from psychosis and aged between 18-64. To qualify, applicants must have an outpatience status of no less than one month before the study begins, been taking a constant dose of psychiatrics medication for at least 4 weeks prior to entry, and meet additional criteria."

Answered by AI

How many participants are taking part in this trial at its maximum capacity?

"Affirmative. Per the information on clinicaltrials.gov, recruitment for this medical investigation is in full swing as of November 14th 2022; it was first posted March 14th 2019 and requires 85 patients from a single site to complete the study."

Answered by AI

Who else is applying?

What state do they live in?
Georgia
How old are they?
18 - 65
What site did they apply to?
University of Minnesota
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis
2019. "Transcranial Direct Current Stimulation and Cognitive Remediation Therapy for Psychosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02085421.
~7 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top